Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters.

Jankovic J, Caskey TC, Stout JT, Butler IJ.

Ann Neurol. 1988 May;23(5):466-9.

PMID:
2455472
2.

Effects of L-5-hydroxytryptophan on monoamine and amino acids turnover in the Lesch-Nyhan syndrome.

Castells S, Chakrabarti C, Winsberg BG, Hurwic M, Perel JM, Nyhan WL.

J Autism Dev Disord. 1979 Mar;9(1):95-103.

PMID:
312282
3.

The use of 5-hydroxytryptophan in a child with Lesch-Nyhan syndrome.

Ciaranello RD, Anders TF, Barchas JD, Berger PA, Cann HM.

Child Psychiatry Hum Dev. 1976 Winter;7(2):127-33.

PMID:
1088261
4.

Lesch-Nyhan syndrome: CSF neurotransmitter abnormalities.

Silverstein FS, Johnston MV, Hutchinson RJ, Edwards NL.

Neurology. 1985 Jun;35(6):907-11.

PMID:
2582310
5.

CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.

Davidson DL, Yates CM, Mawdsley C, Pullar IA, Wilson H.

J Neurol Neurosurg Psychiatry. 1977 Dec;40(12):1136-41.

6.

Further observations on the use of 5-hydroxytryptophan in a child with Lesch-Nyhan syndrome.

Anders TF, Cann HM, Ciaranello RD, Barchas JD, Berger PA.

Neuropadiatrie. 1978 May;9(2):157-66.

PMID:
308621
7.

Developmental variations in CSF monoamine metabolites during childhood.

Hedner J, Lundell KH, Breese GR, Mueller RA, Hedner T.

Biol Neonate. 1986;49(4):190-7.

PMID:
2423144
8.

CSF and urine biogenic amine metabolites in Rett syndrome.

Lekman A, Witt-Engerström I, Holmberg B, Percy A, Svennerholm L, Hagberg B.

Clin Genet. 1990 Mar;37(3):173-8.

PMID:
1691058
9.

Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.

Seifert WE Jr, Foxx JL, Butler IJ.

Ann Neurol. 1980 Jul;8(1):38-42.

PMID:
6157351
10.

Aggression in humans correlates with cerebrospinal fluid amine metabolites.

Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF.

Psychiatry Res. 1979 Oct;1(2):131-9.

PMID:
95232
11.
12.

Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.

Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S.

Biol Psychiatry. 1983 Oct;18(10):1141-52.

PMID:
6197099
13.

Rapid liquid-chromatographic measurement of 3-methoxy-4-hydroxyphenylglycol and other monoamine metabolites in human cerebrospinal fluid.

Langlais PJ, McEntee WJ, Bird ED.

Clin Chem. 1980 May;26(6):786-9. No abstract available.

PMID:
6989518
14.

Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method.

Mena MA, Aguado EG, de Yebenes JG.

Acta Neurol Scand. 1984 Apr;69(4):218-25.

PMID:
6204498
16.
17.
18.

Purine and monoamine metabolites in cerebrospinal fluid.

Edwards NL, Silverstein FS, Johnston MV.

Adv Exp Med Biol. 1986;195 Pt B:53-6. No abstract available.

PMID:
2429511
19.

Monoamine metabolites and ventricular fluid pressure in children.

Yates CM, Minns RA.

Childs Brain. 1981;8(2):138-44.

PMID:
6166434
20.

Risperidone antagonism of self-mutilation in a Lesch-Nyhan patient.

Allen SM, Rice SN.

Prog Neuropsychopharmacol Biol Psychiatry. 1996 Jul;20(5):793-800.

PMID:
8870064
Items per page

Supplemental Content

Support Center